INS and Hypoglycemia: In conclusion, our study demonstrated that glycemic control 12 weeks after switching to once-daily insulin degludec injection with 20% dose reduction was comparable to that in patients treated with twice-daily injection of basal insulin injections and that such switching did not change the frequency of nocturnal hypoglycemia recorded by CGM.